Skip to main content
Equibles

UBS Group AG

Position in KZIA — Kazia Therapeutics Ltd

CIK 1610520 ZURICH, V8
Back to KZIA Full portfolio

Position in KZIA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,141,746
+$1,038,078 QoQ
Shares Held
81,090
+482.0% QoQ
Ownership
0.710%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 35 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KZIA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. KZIA ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in KZIA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,141,746 81,090
2026-03-31 $103,668 13,934
2025-12-31 $1,328 193
2025-09-30 $25,544 3,543
2025-06-30 $18,990 3,029
2025-03-31 $20,502 26,285
2024-12-31 $48,758 27,547
2024-09-30 $107,264 249,452
2024-06-30 $5,367 23,336
2023-12-31 $44 100
2022-12-31 $3,875 6,353
2022-09-30 $4,242 3,857
2022-06-30 $10,374 2,470
2021-12-31 $25,680 3,050
2021-09-30 $4,584 405
2021-03-31 $20,038 1,616
2020-12-31 $24,632 2,851
2020-09-30 $8,916 1,321
2020-06-30 $339 100
2020-03-31 $25,111 8,659